Results 231 to 240 of about 38,830 (350)

Conformationally Locked Peptide–DNA Nanostructures for CRISPR‐Amplified Activity‐Based Sensing

open access: yesAngewandte Chemie, Volume 137, Issue 25, June 17, 2025.
We report a new class of chemical probes, termed cleavable, locked initiator probes (CLIPs). CLIPs are peptide–DNA nanostructures resembling molecular beacons but enable activity‐based CRISPR‐amplified molecular sensing. CLIPs detect various disease‐relevant proteases, yield superior sensitivity compared to commercial probes, and enable the monitoring ...
Dylan M. Snider   +6 more
wiley   +2 more sources

Rapid and robust validation of pooled CRISPR knockout screens using CelFi. [PDF]

open access: yesSci Rep
Loughran AJ   +5 more
europepmc   +1 more source

Formalin‐fixed paraffin‐embedded (FFPE) samples help to investigate transcriptomic responses in wildlife disease

open access: yesMolecular Ecology Resources, Volume 25, Issue 5, July 2025.
Abstract Infectious diseases impact numerous organisms. Knowledge of host‐pathogen interactions and host responses to infection is crucial for conservation and management. Obtaining this knowledge quickly is made increasingly possible by a variety of genomic approaches, yet, for many species the bottleneck to understanding this, remains access to ...
Allison K. Miller   +7 more
wiley   +1 more source

Dad's legacy: Epigenetic reprogramming and paternal inflammatory memory in offspring health

open access: yesJournal of Internal Medicine, Volume 298, Issue 1, Page 16-30, July 2025.
Abstract Over the past decade, numerous reports have highlighted intergenerational and even transgenerational epigenetic effects resulting from parental exposure to diets, toxins, and stress. In many cases, these parentally induced phenotypes do not seem to confer an obvious benefit, making it challenging to understand the evolutionary drivers behind ...
Shamila D. Alipoor   +3 more
wiley   +1 more source

Engineered extracellular vesicles efficiently deliver CRISPR-Cas9 ribonucleoprotein (RNP) to inhibit herpes simplex virus1 infection in vitro and in vivo

open access: yesActa Pharmaceutica Sinica B
Extracellular vesicles (EVs) have recently emerged as a promising delivery platform for CRISPR/Cas9 ribonucleoproteins (RNPs), owing to their ability to minimize off-target effects and immune responses.
Yuanda Wan   +9 more
doaj  

Home - About - Disclaimer - Privacy